Integral Derivatives’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$265K Sell
5,800
-53,600
-90% -$2.66M 0.01% 535
2017
Q4
$2.81M Sell
59,400
-51,900
-47% -$2.55M 0.06% 219
2017
Q3
$5.38M Buy
111,300
+58,300
+110% +$2.9M 0.1% 128
2017
Q2
$2.66M Sell
53,000
-70,600
-57% -$3.22M 0.05% 243
2017
Q1
$5.51M Sell
123,600
-60,400
-33% -$2.51M 0.1% 118
2016
Q4
$7.08M Buy
184,000
+78,000
+74% +$3.05M 0.13% 95
2016
Q3
$4.16M Sell
106,000
-53,000
-33% -$2.16M 0.09% 135
2016
Q2
$6.51M Buy
159,000
+126,700
+392% +$5.06M 0.16% 82
2016
Q1
$1.32M Sell
32,300
-147,200
-82% -$5.45M 0.04% 307
2015
Q4
$6.56M Buy
179,500
+154,200
+609% +$5.89M 0.17% 102
2015
Q3
$914K Sell
25,300
-151,000
-86% -$5.81M 0.03% 523
2015
Q2
$7.11M Buy
176,300
+151,000
+597% +$6.55M 0.19% 93
2015
Q1
$1.09M Buy
25,300
+5,200
+26% +$225K 0.02% 484
2014
Q4
$904K Sell
20,100
-266,400
-93% -$10.8M 0.02% 701
2014
Q3
$11M Buy
+286,500
New +$11.6M 0.2% 76
2014
Q2
Sell
-15,200
Closed -$622K 1470
2014
Q1
$622K Sell
15,200
-113,800
-88% -$4.33M 0.01% 822
2013
Q4
$4.94M Buy
+129,000
New +$4.43M 0.07% 241

Other funds holding ORCL

Integral Derivatives's ORCL Position: Q1 2018 in Review

Integral Derivatives sold out of Oracle (ORCL) in Q1 2018, closing a stake of 56,390 shares — an estimated $2.8M sold.

Integral Derivatives first reported a position in ORCL in Q3 2014 and held it in 8 quarters. The position peaked at $4.9M in Q2 2015. 1,752 funds tracked by Wall St. Rank hold ORCL as of Q1 2018.

  • Integral Derivatives reported no remaining Oracle position as of Q1 2018 after selling out during the quarter.
  • Integral Derivatives sold 56,390 Oracle shares in Q1 2018, an estimated $2.8M.
  • Integral Derivatives first reported a position in Oracle in Q3 2014 and held it in 8 quarters.
  • Integral Derivatives's Oracle position peaked at $4.9M in Q2 2015.
  • 1,752 funds tracked by Wall St. Rank held Oracle as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.